Neurosyphilis

Imagine a disease that can subtly invade the very control center of your body, altering your mind, senses, and movement years after its initial infection. Neurosyphilis is just that — a severe complication of untreated syphilis, where the causative bacterium, Treponema pallidum, infiltrates the central nervous system. Once a devastating and common affliction, its story highlights both the incredible resilience of microscopic invaders and the triumphs and ethical failures of medical science. Neurosyphilis can manifest with a bewildering array of symptoms affecting the brain, spinal cord, eyes, and ears, often mimicking other neurological or psychiatric conditions. Diagnosing neurosyphilis is complex, requiring a combination of clinical history, neurological examination, and a crucial spinal fluid analysis, as no single test is definitive. Despite its severity and diverse presentations, neurosyphilis is highly treatable with antibiotics like penicillin, underscoring the importance of early detection and complete treatment of syphilis.

Source: Wikipedia

AI Summary

Imagine a disease that can subtly invade the very control center of your body, altering your mind, senses, and movement years after its initial infection. Neurosyphilis is just that — a severe complication of untreated syphilis, where the causative bacterium, Treponema pallidum, infiltrates the central nervous system. Once a devastating and common affliction, its story highlights both the incredible resilience of microscopic invaders and the triumphs and ethical failures of medical science.

The Uninvited Guest in the Central Nervous System

Neurosyphilis isn't a separate disease, but rather a serious complication of syphilis — a sexually transmitted infection caused by the spiral-shaped bacterium, Treponema pallidum. When this microscopic invader makes its way into the brain and spinal cord, it can wreak havoc on the central nervous system.

In the modern era of antibiotics, neurosyphilis became far less common. However, recent decades have seen a resurgence, particularly among individuals also living with HIV, highlighting complex interactions between infections and immune systems.

A Chameleon of Symptoms

One of the most challenging aspects of neurosyphilis is its vast array of symptoms. It can affect nearly any part of the central nervous system, meaning its presentation can vary wildly—from subtle changes in mood to severe neurological deficits and even blindness.

While syphilis itself progresses through primary, secondary, latent, and tertiary stages, neurosyphilis is typically categorized into early, intermediate, and late stages, and it can emerge at any point after the initial infection, sometimes decades later.

Early and Intermediate Manifestations

Often, early neurosyphilis shows no clinical symptoms at all, making it a silent threat. When it does, the most common early presentation is meningitis, an inflammation of the protective membranes surrounding the brain and spinal cord. This usually occurs within a year of initial infection.

Symptoms of syphilitic meningitis are similar to other forms of meningitis: severe headache, a stiff neck, sensitivity to light, confusion, nausea, and vomiting. The inflammation can also irritate cranial nerves, sometimes causing facial paralysis or other sensory issues.

In the intermediate stage, typically 5 to 12 years after infection, meningovascular syphilis can emerge. This involves inflammation of the blood vessels supplying the central nervous system, which can restrict blood flow and lead to the death of brain tissue—a stroke. Symptoms depend entirely on which blood vessels are affected, potentially causing weakness, sensory loss, or even problems with eye movement.

Late-Stage Devastation

The late stage of neurosyphilis, often appearing 15 to 25 years post-infection, is characterized by parenchymal syphilis — meaning the actual brain and spinal cord tissue are directly damaged. This most commonly manifests as two severe conditions: tabes dorsalis and general paresis.

Tabes dorsalis, also known as locomotor ataxia, results from the degeneration of nerve fibers in the posterior columns of the spinal cord. Patients might experience sharp, shooting pains, an unsteady wide-based gait, numbness or tingling, and even loss of bowel or bladder control. A peculiar sign called the Argyll Robertson pupil — where the pupils react to focusing on a near object but not to bright light — can also be present.

General paresis, on the other hand, involves a slow, progressive degeneration of the brain itself. This can lead to profound neuropsychiatric symptoms, often mimicking dementia, mania, psychosis, or severe depression. These symptoms can be so severe that a patient eventually becomes bedridden, unable to care for themselves.

Sensory Assault: Ocular and Otosyphilis

Neurosyphilis doesn't spare the senses. Ocular syphilis can affect almost any part of the eye, with uveitis—inflammation of the middle layer of the eye—being the most common form. This can rapidly lead to worsening vision, and without treatment, permanent blindness.

Similarly, otosyphilis targets the vestibulocochlear nerve, which is crucial for hearing and balance. Patients may experience hearing loss, persistent ringing in the ears (tinnitus), dizziness (vertigo), and difficulty maintaining their balance. Both ocular and otosyphilis can occur at any stage of infection and sometimes overlap with other neurological symptoms.

Who's at Risk?

The risk factors for neurosyphilis mirror those for syphilis in general. These include high-risk sexual behaviors, such as unprotected sex and having multiple partners. Historically, syphilis has shown a higher prevalence among males, particularly men who have sex with men.

There's also a significant association between syphilis and HIV infection. This link is partly due to shared risk factors, but a weakened immune system, like that seen in individuals with HIV, might also reduce the body's ability to clear Treponema pallidum from the central nervous system, making neurosyphilis more likely or more severe.

The Path Less Understood

Treponema pallidum, the spirochete responsible, spreads rapidly throughout the body via blood and lymphatic vessels within days or weeks of the initial infection. It can then multiply in the perivascular spaces of almost any organ, including the central nervous system.

Exactly why some syphilis patients develop persistent CNS infection and others don't remains somewhat of a mystery. Scientists also debate whether the symptoms arise solely from the bacteria's invasion or if the body's own immune response to the bacteria within the CNS plays a larger role in the damage.

In primary or secondary syphilis, the invasion of the meninges triggers an immune response, with inflammatory cells like lymphocytes and plasma cells infiltrating the perivascular spaces. This inflammation can harm small blood vessels in the brain and spinal cord. In the tertiary stage, chronic inflammation of CNS arteries, called endarteritis obliterans, leads to the tissue damage seen in meningovascular syphilis.

The late parenchymal forms, tabes dorsalis and general paresis, involve specific types of damage. Tabes dorsalis is thought to be caused by irreversible loss of myelin—the protective sheath around nerve fibers—in the spinal cord's posterior columns. General paresis, however, stems from chronic inflammation of the brain and meninges, leading to brain atrophy and demyelinating plaques, particularly in the frontal and parietal lobes.

The Diagnostic Quest

Diagnosing neurosyphilis is a complex puzzle, as no single test provides all the answers in every case. It requires a careful combination of a patient's clinical history, a thorough neurological examination, and a crucial analysis of cerebrospinal fluid (CSF).

To obtain CSF, doctors perform a lumbar puncture, often called a "spinal tap." A key test on this fluid is the CSF-VDRL. A positive result, especially with neurological symptoms, is generally sufficient for a diagnosis. However, a negative CSF-VDRL doesn't completely rule out neurosyphilis due to its lower sensitivity.

Because of this limitation, other CSF tests that look for specific antibodies against Treponema pallidum are also used. These include the fluorescent treponemal antibody absorption test (FTA-ABS) and the T. pallidum particle agglutination assay (TPPA). These are generally more sensitive than the VDRL but can be less specific.

Other findings in the CSF can also be suggestive, such as elevated white blood cell counts or increased protein levels. However, these are non-specific and can be caused by many conditions, making them less definitive, especially in patients with co-infections like HIV.

A Treatable Affliction

The good news is that neurosyphilis is highly treatable. The standard regimen involves intravenous penicillin G, typically administered for 10 to 14 days. Penicillin has been the cornerstone of syphilis treatment for decades, remaining remarkably effective against Treponema pallidum.

After treatment, follow-up blood serum tests are essential to confirm success, usually performed at 3, 6, 12, and 24 months. A successful treatment is generally indicated by a fourfold drop in the nontreponemal antibody test. All patients diagnosed with syphilis should also be tested for HIV, and their sexual partners evaluated.

For individuals with a penicillin allergy, desensitization to penicillin is often advised. If that's not possible, alternative antibiotics like ceftriaxone may be used. In certain carefully selected cases, doxycycline or tetracycline might also be considered.

The Jarisch–Herxheimer Reaction

A notable complication that can occur during syphilis treatment is the Jarisch–Herxheimer reaction. This is an acute, immune-mediated response that can occur within hours of the first dose of antibiotics. It's thought to be caused by proinflammatory lipoproteins released from the dying bacteria.

Symptoms typically include fever, headache, muscle aches, and a possible intensification of skin rash. While often alarming, it's usually self-limiting and managed with supportive care like anti-fever medications and anti-inflammatory drugs. It's most common in early-stage syphilis, affecting up to 75% of patients with primary and secondary infections.

A Dark Chapter: The Tuskegee Study

The history of neurosyphilis treatment is indelibly marked by one of the most infamous ethical breaches in medical history: the Tuskegee Syphilis Study. This study, conducted by the U.S. Public Health Service, began in 1932 and shockingly continued until 1972.

In this study, researchers knowingly withheld treatment—even after penicillin was discovered to be an effective cure in the 1940s—from African American men with syphilis, without their informed consent. The explicit goal was to observe the natural progression of untreated syphilis, including the development of neurosyphilis and other severe complications.

The study tragically found that a significant percentage of the untreated men developed neurosyphilis, and many died from the complications of the disease. The Tuskegee experiment stands as a stark reminder of the critical importance of ethical research practices and patient autonomy in medicine.

Article

Neurosyphilis

Neurosyphilis is the infection of the central nervous system by Treponema pallidum, the bacterium that causes the sexually transmitted infection syphilis. In the era of modern antibiotics, the majority of neurosyphilis cases have been reported in HIV-infected patients.

Neurosyphilis may present a variety of symptoms that depend on the affected structure of the central nervous system. While early neurosyphilis is often asymptomatic, meningitis is the most common neurological presentation of the early stage. Late neurosyphilis typically involves the brain and spinal cord parenchyma, manifesting as tabes dorsalis and general paresis. Tertiary syphilis can involve several different organ systems, though neurosyphilis may occur at any stage of infection.

Clinical history, a physical neurological examination, and a lumbar puncture to obtain cerebrospinal fluid (CSF) for analysis are crucial for diagnosing neurosyphilis. There is no single laboratory test to confirm the diagnosis of neurosyphilis in all cases. A positive CSF-VDRL test in the presence of neurological symptoms is sufficient for a diagnosis, but additional tests may be needed in certain instances.

Standard treatment is an infusion of intravenous penicillin G for 10 to 14 days. Patients with neurosyphilis should also be evaluated for HIV, and their sexual partners should be properly evaluated by a medical professional.

Signs and symptoms

Neurosyphilis

While the stages of syphilis are categorized as primary, secondary, latent, and tertiary, neurosyphilis is typically categorized into early, intermediate, and late stages. Neurosyphilis may occur any time after initial infection.

Early and intermediate neurosyphilis

Early neurosyphilis often has no clinical symptoms. Meningitis is the most-common neurological presentation in early syphilis, typically arising within one year of initial infection. Symptoms of syphilitic meningitis are similar to other forms of meningitis, including headache, neck stiffness, photophobia, confusion, nausea, and vomiting. Meningeal inflammation may also affect the cranial nerves, most commonly the facial nerve, presenting as facial paralysis. Cerebral gummas, which are caused by granulomatous destruction of the brain from syphilis, can also cause symptoms of meningitis.

Meningovascular syphilis is often in the intermediate stage of neurosyphilis, typically presenting 5 to 12 years after infection. It is due to inflammation of the blood vessels supplying the central nervous system, resulting in the death of brain tissue called ischemia. It may present as stroke or spinal cord injury. Signs and symptoms vary with the blood vessel that is affected. The middle cerebral artery is most often affected, causing a variety of symptoms including weakness, sensory loss, eye deviation, and hemineglect syndrome.

Late neurosyphilis

Tabes dorsalis is a form of late neurosyphilis that affects the posterior columns of the spinal cord.

Parenchymal syphilis occurs in the late stage of neurosyphilis, with average presentation occurring 15 to 25 years after initial infection. This stage of the disease is generally in the form of tabes dorsalis or general paresis. Tabes dorsalis, also called locomotor ataxia, describes a constellation of symptoms resulting from a degenerative process of the posterior columns of the spinal cord. Symptoms include pain, ataxic wide-based gait, paresthesias, bowel or bladder incontinence, loss of position and vibratory sense, acute episodic gastrointestinal pain, Charcot joints, and reduced reflexes. The Argyll Robertson pupil, which is a condition where the pupils do not constrict to bright light but constrict when focusing on a near object (accommodation reflex), is another feature that may be present.

Argyll Robertson pupils, a clinical feature of neurosyphilis, are characterized by pupils that do not react to light but have an intact accommodation reflex.

Another late form of neurosyphilis is general paresis, which is a slow degenerative process of the brain. Neuropsychiatric symptoms might appear due to overall damage to the brain. These symptoms can make the diagnosis more difficult and can include symptoms of dementia, mania, psychosis, depression, and delirium. These symptoms may progress to the point of where a patient becomes bedridden.

Ocular syphilis and otosyphilis

Nearly any part of the eye may be involved in neurosyphilis, resulting in ocular syphilis. The most common form of ocular syphilis is uveitis. Other forms include episcleritis, vitritis, retinitis, papillitis, retinal detachment, and interstitial keratitis. Patients typically present with worsening vision.

Otosyphilis refers to a type of neurosyphilis that affects the vestibulocochlear nerve, causing issues with hearing and balance. Signs include loss of hearing, tinnitus, vertigo, and gait instability.

Ocular syphilis and otosyphilis may occur at any point after initial infection, and its presentation can overlap with other symptoms of neurosyphilis.

Risk factors

Neurosyphilis

There are several risk-factors of neurosyphilis that overlap with the risk factors for syphilis and other STIs, including high-risk sexual behavior, i.e. unprotected sex, and multiple sexual partners. A significant proportion of syphilis cases are seen among males, especially men who have sex with men. There is also an association between patients who are infected with syphilis and HIV. The link between syphilis and HIV is thought to be because of shared risk factors. Another possibility is that a weakened immune system, such as those in people with HIV, may decrease the body's ability to clear the infection from the central nervous system. The HIV infection antiretroviral therapy (ART) suppresses HIV transmission but not syphilis transmission.

Pathophysiology

Neurosyphilis

Treponema pallidum is the spirochete-shaped bacteria that causes neurosyphilis. The pathogenesis is not fully known, in part due to fact that the organism is not easily cultured, making scientific experiments difficult. Within days to weeks after initial infection, T. pallidum spreads throughout the body via blood and lymphatic vessels. The organism may proliferate in the perivascular spaces of nearly any organ, including the central nervous system (CNS). It is unclear why some patients with syphilis develop a persistent CNS infection and others do not. Scientists have also debated if neurosyphilis is the result the bacterial invasion of the CNS or the immune system responding to bacteria in the CNS.

In primary or secondary syphilis, invasion of the protective membrane of the brain called the meninges may result in lymphocytic and plasma cell infiltration of perivascular spaces. The immune response may affect the brain and spinal cord through inflammation and necrosis of small blood vessels. In tertiary syphilis, reactivation of a chronic latent infection causes severe inflammation of CNS arteries called endarteritis obliterans, leading to meningovascular syphilis.

The parenchymal syphilis, present late in neurosyphilis as tabes dorsalis and general paresis. Tabes dorsalis thought to be due to irreversible loss of myelin in nerve fibers of the posterior columns of the spinal cord involving the lumbosacral and lower thoracic levels. General paresis is caused by chronic inflammation of meninges and brain, leading to fibrosis of the meninges, atrophy of the cerebral cortex, and the formation of demyelinating plaques, particularly in the frontal and parietal lobes. Rarely, T. pallidum may invade any structures of the eye (such as cornea, anterior chamber, vitreous and choroid, and optic nerve) and cause local inflammation and edema.

Diagnosis

Neurosyphilis

There is no single test that is sufficient on its own to make a diagnosis of neurosyphilis in every case. Serum studies are used to determine if a patient has preexisting syphilis. Common serum studies to diagnose syphilis include the rapid plasma reagin and the Venereal Disease Research Laboratory (VDRL) test. To diagnose neurosyphilis, a clinical history, physical examination, and cerebrospinal fluid (CSF) analysis are required. Lumbar puncture ("spinal tap") is the procedure to obtain CSF. The VDRL test of the CSF is a common test for making a diagnosis of neurosyphilis. A positive VDRL test in the presence of neurological symptoms is sufficient to confirm a diagnosis of neurosyphilis. However, a negative VDRL result does not rule out neurosyphilis. Due to the low sensitivity of the VDRL test, CSF analyses that specifically look for antibodies against T. pallidum, such as the fluorescent treponemal antibody absorption test (FTA-ABS) and the T. pallidum particle agglutination assay (TPPA), are also used in certain cases. The FTA-ABS test is more sensitive but less specific than the VDRL test. Reported sensitivity of different tests for neurosyphilis are variable.

Other components of CSF analysis can be helpful for diagnosing neurosyphilis. The CSF white blood cell count is often elevated in neurosyphilis, but this finding is nonspecific and can be unreliable in patients with other infections such as HIV. Similarly, an elevated CSF protein may be suggestive of neurosyphilis, but it is a nonspecific result.

Treatment

Neurosyphilis

Penicillin is used to treat neurosyphilis. The Centers for Disease Control and Prevention recommend the following regimen:

• Aqueous penicillin G 3–4 million units every four hours (18–24 million units per day) for 10 to 14 days.

• One daily intramuscular injection of procaine penicillin G 24 million units and oral probenecid 500 mg four times daily, both for 10 to 14 days

Follow-up blood serum tests are generally performed at 3, 6, 12, and 24 months to ensure successful treatment. The CDC states that repeated CSF studies are unnecessary for people with intact immune systems and people with HIV who are on adequate ART. All patients with syphilis should be tested for HIV infection. All cases of syphilis should be reported to public health authorities and public health departments can aid in partner notification, testing, and determining need for treatment.

The treatment success is measured with a fourfold drop in the nontreponemal antibody test. In early-stage syphilis drop should occur in 6–12 months; in late syphilis drop can take 12–24 months. Titers may decline more slowly in persons who have previously had syphilis.

In people who are allergic to penicillin, initiation of penicillin desensitization is advised. If desensitization is not possible, the CDC recommends ceftriaxone as an alternative. Doxycycline or tetracycline may be considered in select patients for treating neurosyphilis.

Complications

The Jarisch–Herxheimer reaction is an immune-mediated response to syphilis therapy occurring within 2–24 hours. The exact mechanisms of reaction are unclear, however most likely caused by proinflammatory treponemal lipoproteins that are released from dead and dying organisms following antibiotic treatment. It is typically characterized by fever, headache, myalgia, and possibly intensification of skin rash. It most often occurs in early-stage syphilis (up to 50%-75% of patients with primary and secondary syphilis). It is usually self-limiting and managed with antipyretics and nonsteroidal anti-inflammatory medications.

History

Neurosyphilis

A subject of the Tuskegee Syphilis Study getting their blood drawn.

Historically, syphilis was studied under the Tuskegee study, often cited as an example of unethical human experimentation. The study began without informed consent of the subjects and was continued by the United States Public Health Service until 1972. The researchers failed to notify and withheld treatment for patients despite knowing penicillin was found as an effective cure for syphilis. After four years of follow-up, neurosyphilis was identified in 26.1% of patients vs. 2.5% of controls. After 20 years of follow-up, 6.5% showed signs of neurosyphilis and 40% had died from other causes.